18.11.2014 Views

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601 3533<br />

MKP Broj objave europske Naziv izuma<br />

prijave patenta<br />

(51) (97) (54)<br />

C12N 5/06 (2006.01) EP 2<strong>09</strong>4726 * COMPOSITIONS AND METHODS RELATED TO TOLL-LIKE RECEPTOR-3<br />

C12N 5/06 (2006.01) EP 2<strong>09</strong>8595 * HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION<br />

COMPRISING THE SAME<br />

C12N 5/10 (2006.01) EP 2087002 * COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE<br />

C12N 5/10 (2006.01) EP 2<strong>09</strong>5127 * METHODS FOR SCREENING AND TREATMENT INVOLVING THE GENES GYPC, AGPAT3,<br />

AGL, PVRL2, HMGB 3, HSDL2 AND/OR LDB2<br />

C12N 5/10 (2006.01) EP 2<strong>09</strong>6122 * ANTI-HUMAN DLK-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO<br />

C12N 5/12 (2006.01) EP 2087002 * COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE<br />

C12N 5/12 (2006.01) EP 2<strong>09</strong>9827 * ANTAGONIST ANTI-NOTCH3 ANTIBODIES AND THEIR USE IN THE PREVENTION AND<br />

TREATMENT OF NOTCH3-RELATED DISEASES<br />

C12N 5/16 (2006.01) EP 2087102 * ENHANCEMENT OF HYBRIDOMA FUSION EFFICIENCIES THROUGH CELL<br />

SYNCHRONIZATION<br />

C12N 5/18 (2006.01) EP 2087103 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

C12N 5/18 (2006.01) EP 2089514 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

C12N 5/18 (2006.01) EP 2<strong>09</strong>2058 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

C12N 7/02 (2006.01) EP 2087104 * MEDIUM SUPPLEMENT FOR VIRUS PRODUCTION<br />

C12N 7/04 (2006.01) EP 2<strong>09</strong>7517 * MODIFIED VACCINIA VIRUS STRAINS FOR USE IN DIAGNOSTIC AND THERAPEUTIC<br />

METHODS<br />

C12N 9/02 (2006.01) EP 2<strong>09</strong>7528 * BUTANOL PRODUCTION IN A EUKARYOTIC CELL<br />

C12N 9/04 (2006.01) EP 2<strong>09</strong>7528 * BUTANOL PRODUCTION IN A EUKARYOTIC CELL<br />

C12N 9/10 (2006.01) EP 2<strong>09</strong>7528 * BUTANOL PRODUCTION IN A EUKARYOTIC CELL<br />

C12N 9/24 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />

CONTAINING MODIFIED TOXINS AND USES THEREOF<br />

C12N 9/88 (2006.01) EP 2<strong>09</strong>7528 * BUTANOL PRODUCTION IN A EUKARYOTIC CELL<br />

C12P 21/02 (2006.01) EP 2<strong>09</strong>4726 * COMPOSITIONS AND METHODS RELATED TO TOLL-LIKE RECEPTOR-3<br />

C12P 21/02 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />

CONTAINING MODIFIED TOXINS AND USES THEREOF<br />

C12P 21/06 (2006.01) EP 2<strong>09</strong>9414 * HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING<br />

C12P 21/08 (2006.01) EP 2087002 * COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE<br />

C12P 21/08 (2006.01) EP 2087103 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

C12P 21/08 (2006.01) EP 2089514 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

C12P 21/08 (2006.01) EP 2<strong>09</strong>6122 * ANTI-HUMAN DLK-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO<br />

C12P 21/08 (2006.01) EP 2<strong>09</strong>9825 * RECOMBINANT ANTIBODIES AGAINST HEPATITIS C VIRUS AND METHODS OF<br />

OBTAINING AND USING SAME<br />

C12P 7/06 (2006.01) EP 2<strong>09</strong>9910 * GLOBAL TRANSCRIPTION MACHINERY ENGINEERING<br />

C12P 7/16 (2006.01) EP 2<strong>09</strong>7528 * BUTANOL PRODUCTION IN A EUKARYOTIC CELL<br />

C12Q 1/00 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />

CONTAINING MODIFIED TOXINS AND USES THEREOF<br />

C12Q 1/00 (2006.01) EP 2<strong>09</strong>9825 * RECOMBINANT ANTIBODIES AGAINST HEPATITIS C VIRUS AND METHODS OF<br />

OBTAINING AND USING SAME<br />

C12Q 1/02 (2006.01) EP 2<strong>09</strong>8595 * HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION<br />

COMPRISING THE SAME<br />

C12Q 1/48 (2006.01) EP 2089710 * A METHOD FOR PHARMACOLOGICALLY PROFILING COMPOUNDS<br />

C12Q 1/68 (2006.01) EP 2089540 * GENETIC VARIATIONS ASSOCIATED WITH TUMORS<br />

C12Q 1/68 (2006.01) EP 2<strong>09</strong>2074 * ASSESSMENT OF OOCYTE COMPETENCE<br />

C12Q 1/68 (2006.01) EP 2<strong>09</strong>2079 * PHOTOGRAPIC DETERMINATION OF ANALYTES<br />

C12Q 1/68 (2006.01) EP 2<strong>09</strong>3297 Agents for treatment or prevention of an allergic disorder<br />

C12Q 1/68 (2006.01) EP 2<strong>09</strong>4866 * DIAGNOSIS AND TREATMENT OF BREAST CANCER<br />

C12Q 1/68 (2006.01) EP 2<strong>09</strong>5127 * METHODS FOR SCREENING AND TREATMENT INVOLVING THE GENES GYPC, AGPAT3,<br />

AGL, PVRL2, HMGB 3, HSDL2 AND/OR LDB2<br />

C12Q 1/68 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />

CONTAINING MODIFIED TOXINS AND USES THEREOF<br />

C12Q 1/68 (2006.01) EP 2<strong>09</strong>7539 * POLYMORPHISMS IN THE UROCORTIN 3 GENE AND THEIR ASSOCIATIONS WITH<br />

MARBLING AND SUBCUTANEOUS FAT DEPTH IN BEEF CATTLE<br />

C12Q 1/68 (2006.01) EP 2<strong>09</strong>9937 * GENETIC SUSCEPTIBILITY VARIANTS OF TYPE 2 DIABETES MELLITUS<br />

C12Q 1/70 (2006.01) EP 2<strong>09</strong>9825 * RECOMBINANT ANTIBODIES AGAINST HEPATITIS C VIRUS AND METHODS OF<br />

OBTAINING AND USING SAME<br />

C14B 17/00 (2006.01) EP 2088853 * INDIVIDUAL IDENTIFICATION AND TRANSPORT SYSTEM FOR USE IN THE HANDLING OF<br />

KILLED FURRED ANIMALS AND PELTS FROM FURRED ANIMALS<br />

C21D 1/34 (2006.01) EP 2014777 Method and device for thermal treatment of metal sheet<br />

C21D 1/673 (2006.01) EP 2014777 Method and device for thermal treatment of metal sheet<br />

C21D 9/46 (2006.01) EP 2014777 Method and device for thermal treatment of metal sheet<br />

C21D 9/46 (2006.01) EP 2020451<br />

Method of manufacturing sheets of steel with high levels of strength and ductility, and sheets<br />

produced using same<br />

C22C 38/00 (2006.01) EP 2020451<br />

Method of manufacturing sheets of steel with high levels of strength and ductility, and sheets<br />

produced using same<br />

C22C 38/04 (2006.01) EP 2020451<br />

Method of manufacturing sheets of steel with high levels of strength and ductility, and sheets<br />

produced using same<br />

ISSN 1331-2030

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!